Dow Up 0.07% Nasdaq Up 0.61%

Sunesis Pharmaceuticals, Inc. (SNSS)

-NasdaqCM
2.25 Up 0.03(1.35%) Nov 26, 4:00PM EST
Prev Close:2.22
Open:2.25
Bid:N/A
Ask:2.50 x 500
1y Target Est:1.96
Beta:3.04
Next Earnings Date:N/A
Day's Range:2.16 - 2.29
52wk Range:1.00 - 8.46
Volume:1,230,071
Avg Vol (3m):2,643,120
Market Cap:139.39M
P/E (ttm):N/A
EPS (ttm):-0.85
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for SNSS

Comparison

Symbol% ChgMkt Cap
SNSSUp 1.35%139.39M
AZNUp 0.34%93.35B
PFEUp 2.07%195.95B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):20.14
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.84
Quarterly EPS Est (Dec-14) :-0.18
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Sunesis Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of oncology therapeutics for the treatment of solid and hematologic cancers. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback